More than 100 million people in Europe and beyond trust Zentiva’s medicines. We continue to expand into multiple new territories and enlarge our portfolio in key therapeutical areas, like cardiology and circulation, diabetes, oncology, respiratory, CNS and consumer health.

In collaboration with BusinessEurope and EuroChambers, we engage in dialogues aimed at shaping a competitive and sustainable industrial policy for the EU, emphasizing secure medicines manufacturing and supply chains. These partnerships reflect our proactive stance on political influence and public affairs activities, guided by a stringent code of conduct prioritizing transparency, competition, and ethical engagement. Our efforts are directed towards supporting policies that mitigate drug shortages, enhance healthcare resilience, and advance environmental stewardship within the pharmaceutical sector, in line with our overarching Sustainability objectives.